Trial Profile
A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of DW-ES(B) and Megace Under Fed Conditions in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Megestrol (Primary)
- Indications Anorexia; Cachexia
- Focus Pharmacokinetics
- Sponsors Daewon Pharmaceutical
- 09 May 2012 New trial record